Coronavirus disease 2019: changing the future of emergency epistaxis management.
J Laryngol Otol
; 135(8): 675-679, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1232054
ABSTRACT
BACKGROUND:
Acute epistaxis can be a life-threatening airway emergency, requiring in-patient admission. The coronavirus disease 2019 pandemic placed significant strain on hospital resources, and management has shifted towards an out-patient-centred approach.METHODS:
A five-month single-centre retrospective study was undertaken of all epistaxis patients managed by the ENT department. A pre-coronavirus disease 2019 pandemic group was managed with pre-existing guidelines, compared to new guidelines for the coronavirus disease 2019 pandemic group. A telephone survey was performed on out-patients with non-dissolvable packs to assess patient comfort and satisfaction.RESULTS:
A total of 142 patients were seen. The coronavirus disease 2019 pandemic group had significantly more patients aged over 65 years (p = 0.004), an increased use of absorbable dressings and local haemostatic agents (Nasopore and Surgiflo), and fewer admissions (all p < 0.0005). Rates of re-presentation and morbidity, and length of hospital stay were similar. The telephone survey revealed out-patient management to be efficacious and feasible.CONCLUSION:
The coronavirus disease 2019 pandemic has shifted epistaxis management towards local haemostatic agents and out-patient management; this approach is as safe and effective as previously well-established regimens.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Epistaxis
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
J Laryngol Otol
Journal subject:
Otolaryngology
Year:
2021
Document Type:
Article
Affiliation country:
S0022215121001456
Similar
MEDLINE
...
LILACS
LIS